Listed

IGC Pharma, Inc.

IGCNYSECIK 1326205HealthcareFiscal year ends Dec 31

Reports and events: 271 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

IGC Pharma, Inc., Reports and events
FiledFormWhat it isAccession number
2015-08-1416:03 ET10-QQuarterly reportPeriod 2015-06-300001185185-15-002205
2015-07-2416:01 ETDEF 14AProxy statementPeriod 2015-08-250001185185-15-001915
2015-07-1420:30 ET10-KAnnual reportPeriod 2015-03-310001185185-15-001808
2015-02-1716:02 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001185185-15-000327
2015-02-1216:38 ET10-QQuarterly reportPeriod 2014-12-310001185185-15-000287
2015-02-0408:00 ET8-K3.03 Change to security holders’ rights; 9.01 Financial statements and exhibits0001185185-15-000205
2014-12-2315:54 ET8-K1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits0001185185-14-003439
2014-11-2520:36 ETSC 13DOwnership report, active investor0001185185-14-003249
2014-11-1319:46 ET10-QQuarterly reportPeriod 2014-09-300001185185-14-003021
2014-09-1514:52 ET8-K1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results0001185185-14-002479
2014-08-2810:00 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001185185-14-002341
2014-08-1416:13 ET10-QQuarterly reportPeriod 2014-06-300001185185-14-002203
2014-08-0413:13 ETDEF 14AProxy statementPeriod 2014-08-250001185185-14-001950
2014-07-1516:07 ET10-KAnnual reportPeriod 2014-03-310001185185-14-001804
2014-07-1517:58 ET8-K/A8.01 Other events; 9.01 Financial statements and exhibits0001185185-14-001794
2014-07-1517:53 ET10-K/AAnnual report, amendedPeriod 2013-03-310001185185-14-001791
2014-07-0313:30 ET8-K3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits0001185185-14-001712
2014-06-1020:43 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001185185-14-001553
2014-06-0517:55 ET8-K1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits0001185185-14-001526
2014-04-0317:27 ET8-K1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits0001185185-14-000855
2014-03-2615:18 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits0001185185-14-000643
2014-03-1408:54 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001185185-14-000546
2014-02-1416:24 ET10-QQuarterly reportPeriod 2013-12-310001185185-14-000346
2014-02-0617:49 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001185185-14-000255
2014-01-3110:00 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001185185-14-000223
2013-11-0817:25 ET10-QQuarterly reportPeriod 2013-09-300001185185-13-002348
2013-09-3016:15 ET8-K5.07 Shareholder vote results0001185185-13-002125
2013-09-0414:26 ETDEF 14AProxy statementPeriod 2013-09-300001185185-13-001963
2013-08-2617:22 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001185185-13-001910
2013-08-1617:25 ET10-QQuarterly reportPeriod 2013-06-300001185185-13-001853
2013-07-1616:17 ET10-KAnnual reportPeriod 2013-03-310001185185-13-001473
2013-07-0118:46 ET8-K4.01 Change of auditor; 9.01 Financial statements and exhibits0001185185-13-001385
2013-04-1518:18 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001185185-13-000816
2013-04-0413:08 ET8-K2.01 Completion of an acquisition or disposition; 9.01 Financial statements and exhibits0001185185-13-000774
2013-03-2716:05 ET8-K4.01 Change of auditor; 9.01 Financial statements and exhibits0001185185-13-000620
2013-02-1308:05 ET10-QQuarterly reportPeriod 2012-12-310001185185-13-000299
2013-02-0716:51 ET8-K3.01 Delisting notice; 3.03 Change to security holders’ rights; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001185185-13-000264
2013-01-1608:31 ET8-K3.01 Delisting notice; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001185185-13-000121
2012-12-2812:38 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001185185-12-002876
2012-12-1417:06 ET8-K3.01 Delisting notice; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001185185-12-002781
2012-11-1416:05 ET10-QQuarterly reportPeriod 2012-09-300001185185-12-002546
2012-11-0115:03 ET8-K3.01 Delisting notice; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001185185-12-002352
2012-10-1815:00 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001185185-12-002248
2012-10-1213:06 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits0001185185-12-002199
2012-09-1312:51 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001185185-12-002033
2012-09-1016:02 ET8-K5.07 Shareholder vote results0001185185-12-002011
2012-08-2113:51 ET10-Q/AQuarterly report, amendedPeriod 2012-06-300001185185-12-001906
2012-08-2017:18 ET10-QQuarterly reportPeriod 2012-06-300001185185-12-001899
2012-08-0616:01 ET8-K5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits0001185185-12-001643
2012-08-0219:46 ETDEF 14AProxy statementPeriod 2012-09-070001185185-12-001614

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 6, 2026, 16:27 ET. Listed shows no prices and gives no investment advice.